Ori Gutwerg's most recent trade in ANI Pharmaceuticals Inc was a trade of 5,873 Common Stock done at an average price of $86.5 . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 86.53 per share. | 12 Aug 2025 | 5,873 | 84,024 (0%) | 0% | 86.5 | 508,191 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 60.07 per share. | 15 May 2025 | 881 | 89,897 (0%) | 0% | 60.1 | 52,922 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.62 per share. | 07 Mar 2025 | 3,314 | 90,778 (0%) | 0% | 60.6 | 200,895 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 05 Mar 2025 | 5,084 | 94,092 (0%) | 0% | 60 | 305,040 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.49 per share. | 05 Mar 2025 | 300 | 99,476 (0%) | 0% | 31.5 | 9,447 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 05 Mar 2025 | 300 | 99,176 (0%) | 0% | 60.0 | 18,009 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 300 | 13,204 | - | - | Stock Option (right to buy) | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,570 | 99,176 (0%) | 0% | 61.9 | 97,167 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 15,668 | 92,895 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 10,444 | 103,339 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,426 | 101,913 (0%) | 0% | 58.9 | 84,020 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,167 | 100,746 (0%) | 0% | 58.9 | 68,760 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 67.00 per share. | 05 Jun 2024 | 2,985 | 77,227 (0%) | 0% | 67 | 199,995 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 2,494 | 80,212 (0%) | 0% | 66.7 | 166,375 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,570 | 82,706 (0%) | 0% | 67.7 | 106,242 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.55 per share. | 15 Feb 2024 | 1,244 | 84,276 (0%) | 0% | 57.5 | 71,592 | Common Stock |
| ANI Pharmaceuticals Inc | Gutwerg Ori | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,763 | 75,678 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Gutwerg Ori | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 9,842 | 85,520 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 62.39 per share. | 23 Aug 2023 | 13,502 | 62,974 (0%) | 0% | 62.4 | 842,390 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 13,502 | 13,504 | - | - | Stock Option (right to buy) | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.49 per share. | 23 Aug 2023 | 13,502 | 76,476 (0%) | 0% | 31.5 | 425,178 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Sale of securities on an exchange or to another person at price $ 62.39 per share. | 23 Aug 2023 | 2,059 | 60,915 (0%) | 0% | 62.4 | 128,461 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 1,756 | 34,613 (0%) | 0% | 44.2 | 77,668 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 586 | 34,027 (0%) | 0% | 44.2 | 25,919 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 51,396 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 62,974 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.04 per share. | 15 Feb 2023 | 1,275 | 36,369 (0%) | 0% | 45.0 | 57,426 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 6,476 | 37,644 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 19,428 | 31,168 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.25 per share. | 15 Feb 2022 | 1,167 | 11,740 (0%) | 0% | 40.3 | 46,972 | Common Stock |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 27,006 | 27,006 | - | - | Stock Option (right to buy) | |
| ANI Pharmaceuticals Inc | Ori Gutwerg | SVP, GENERICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 12,907 | 12,907 (0%) | 0% | 0 | Common Stock |